Review of lipoic acid: From a clinical therapeutic agent to various emerging biomaterials

β-amyloid peptide deposition

ATP

adenosine triphosphate

CMX-2043

α-N-[(R)-1,2-dithio-lane-3-pentanoyl]-L-glutamyl-L-alanine

DHL-TauZnNa

(N-[6,8-dimercaptooctanoyl]-2-aminoethane-sulfonate zinc complex

DTT

1,4-dithio-D,L-threitol

EMT

epithelial-mesenchymal transition

EDC

carbodiimide activation

MDDSs

multivalent drug delivery system

PDH

pyruvate dehydrogenase

PI3K

phosphatidylinositol-3-kinase

R/R AML

relapsed/refractory acute myeloid leukemia

TKN

thioketal nanoparticle

TEAEs

treatment-related adverse events

CPI-613

6,8-Bis-benzylsulfanyloctanoic acid, devimistat

DHL-HisZnNa

N-(dihydrolipoyl)-l-histidinate zinc complex

DMXAA

5-methylethonone-4-acetic acid

DIB

1,3-diisopropenylbenzene

EPR

enhanced permeability and retention

FAD

flavin adenine dinucleotide

IRS1

insulin receptor substrate-1

KGDH

α-ketoglutarate dehydrogenase

MCI

mild cognitive impairment

mPEG

methoxy-poly(ethylene) glycol

NDDS

nanomedicine delivery system

PGMA

polymethyl methacrylate

ROS

reactive oxygen species

SAMs

self-assembled monolayers

TCA cycle

tricarboxylic acid cycle

留言 (0)

沒有登入
gif